#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Philadelphia positive acute lymphocytic leukaemia Friedreich's ataxia Henoch-Schonlein purpura Leiomyosarcoma Breast angiosarcoma Allogenic stem cell transplantation Mucopolysaccharidosis II Leukaemia Langerhans cell sarcoma Selective polysaccharide antibody deficiency Acute leukaemia Angiosarcoma recurrent Dermatomyositis Amyotrophic lateral sclerosis Rosai-Dorfman syndrome More trials…

    Learn about Rare Diseases

    Ehlers-Danlos syndrome Ocular melanoma – Life with Disease Cystic fibrosis lung – Diagnostics Cystic fibrosis – Diagnostics Paroxysmal nocturnal haemoglobinuria – Life with Disease SAPHO syndrome Acquired haemophilia – Diagnostics Synovial sarcoma recurrent – Basic Information Noonan syndrome – Life with Disease Hyperoxaluria – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Losartan [18F]-Altanserin Corylus Avellana L. GSKVX000000044501 GT-002 Timothy Grass Pollen Extract Clindamycin Phosphate Cilastatin Mercaptamine Bi 764532 Paclitaxel Albumin-Bound L-Tyrosine Treg02 Siponimod Calcium Garadacimab Rosuvastatin Calcium Namilumab Vb10.16 Ferric Carboxymaltose More therapies…

    Learn about Your Condition

    Herpes simplex meningitis Peritoneal neoplasm Klinefelter's syndrome Bladder cancer recurrent Plasma cell myeloma recurrent Hyperplasia adrenal Tetanus B-cell lymphoma recurrent Glanzmann's disease Ewing's sarcoma metastatic Oesophageal achalasia Ventricular tachycardia Genitourinary tract neoplasm Adrenocortical carcinoma Osteopenia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Faceland Clinics, location Utrecht

Faceland Clinics, location Utrecht

Franciscusdreef 38C, Utrecht, 3565 AC, Netherlands

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing the Effectiveness and Safety of Botulinum Toxin Type A Products for Treating Frown Lines in Adults

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Skin wrinkling
    Investigated Drugs:
    • Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
    • Botulinum Toxin Type A
    • Botulinum Toxin Type A – Haemagglutinin Complex
    The Netherlands

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!